secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2025-12-11T23:59:59+00:00
Accession:  0001493152-25-027219
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte shareholders elect all five directors, ratify auditor, approve stock plan increase
--------------------------------------------------------------------------------

- All five director nominees elected: Geordan Pursglove, Jason Sawyer, Dr. Michael Holloway, Lourdes Felix, Guy Primus.
- Ratification of Weinberg & Company as auditor approved with 3,080,890 for, 36,370 against, 79 abstain.
- Stock plan amendment to increase shares from 2.75M to 3.5M approved with 1,984,980 for, 74,134 against, 1,500 abstain.
- Broker non-votes of ~1.06M on director elections and plan amendment.
- Meeting had 3,117,339 shares present out of 5,635,467 shares entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315225027219/0001493152-25-027219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315225027219/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-027219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer